La Trobe researchers have made a discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and ...
Insufficient sleep is one of the strongest predictors of shorter life expectancy in the U.S., surpassed only by smoking. That's according to a new nationwide analysis published in the journal SLEEP ...
Justin Stebbing does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
T cell engagers, including Imdelltra, show promise in small cell lung cancer, outperforming chemotherapy in trials and changing the standard of care. Antibody-drug conjugates like I-DXd and ABBV-706 ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
HAMILTON, ON, Nov. 12, 2025 /PRNewswire/ - AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, announced that it has successfully supplied the first dose of Ariceum Therapeutics' ...
The MarketWatch News Department was not involved in the creation of this content. HAMILTON, ON, Nov. 12, 2025 /PRNewswire/ - AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, ...
BERLIN, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Ariceum Therapeutics (Ariceum), a targeted radiotherapeutics company dedicated to setting new standards in cancer care, today announced that the first patient ...
A pharmacist holds a Pfizer and BioNTech COVID-19 vaccine shot on Thursday, April 24, 2025, in Portland, Ore. University of Florida researchers found that advanced lung and skin cancer patients lived ...
A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's immune system to target and eliminate cancer cells appeared to reduce the ...
Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback